Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
1. To observe clinical and bacteriologic responses of different regimens of piperacillin/tazobactam (4.5g q6h, prolonged or intermittent infusion) for treatment of nosocomial pneumonia. 2. To describe the pharmacokinetic profile of piperacillin/tazobactam (4.5g q6h, prolonged or intermittent infusion) in patients with nosocomial pneumonia. 3. To assess the safety profiles of piperacillin/tazobactam 4.5g q6h, prolonged or intermittent infusion in patients with nosocomial pneumonia.
Epistemonikos ID: 39de39b230da2389e86439995abbd252c26a8663
First added on: May 11, 2024